ATE210460T1 - Zusammensetzungen, welche adp-ribosyltransferase- aktivität aufweisen und methoden für ihre herstellung und die verwendung derselben - Google Patents

Zusammensetzungen, welche adp-ribosyltransferase- aktivität aufweisen und methoden für ihre herstellung und die verwendung derselben

Info

Publication number
ATE210460T1
ATE210460T1 AT96919136T AT96919136T ATE210460T1 AT E210460 T1 ATE210460 T1 AT E210460T1 AT 96919136 T AT96919136 T AT 96919136T AT 96919136 T AT96919136 T AT 96919136T AT E210460 T1 ATE210460 T1 AT E210460T1
Authority
AT
Austria
Prior art keywords
adp
production
methods
transferase activity
compositions exhibiting
Prior art date
Application number
AT96919136T
Other languages
English (en)
Inventor
Harvey R Kaslow
Original Assignee
Harvey R Kaslow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvey R Kaslow filed Critical Harvey R Kaslow
Application granted granted Critical
Publication of ATE210460T1 publication Critical patent/ATE210460T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96919136T 1995-06-07 1996-06-04 Zusammensetzungen, welche adp-ribosyltransferase- aktivität aufweisen und methoden für ihre herstellung und die verwendung derselben ATE210460T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/482,758 US6056960A (en) 1995-06-07 1995-06-07 Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof
PCT/US1996/009174 WO1996040228A1 (en) 1995-06-07 1996-06-04 Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof

Publications (1)

Publication Number Publication Date
ATE210460T1 true ATE210460T1 (de) 2001-12-15

Family

ID=23917340

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96919136T ATE210460T1 (de) 1995-06-07 1996-06-04 Zusammensetzungen, welche adp-ribosyltransferase- aktivität aufweisen und methoden für ihre herstellung und die verwendung derselben

Country Status (8)

Country Link
US (3) US6056960A (de)
EP (1) EP0836480B1 (de)
JP (1) JPH11512076A (de)
AT (1) ATE210460T1 (de)
AU (1) AU6176596A (de)
CA (1) CA2224160A1 (de)
DE (1) DE69617956T2 (de)
WO (1) WO1996040228A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10010165A1 (de) * 2000-03-01 2001-09-20 Hartmut Merz C O Medizinische Mittel zur Tumorbekämpfung
WO2001068853A2 (en) * 2000-03-14 2001-09-20 The Johns Hopkins University School Of Medicine Immunogenic ovarian cancer genes
US20030162733A1 (en) * 2000-11-27 2003-08-28 Haynes Joel R. Nucleic acid adjuvants
CN1317034C (zh) * 2000-11-27 2007-05-23 宝德杰克特疫苗有限公司 核酸佐剂
WO2007027967A2 (en) * 2005-08-31 2007-03-08 Eagleforce Associates System for hypothesis generation
US9045556B2 (en) 2007-02-07 2015-06-02 Nec Corporation Therapeutic agent for cancer
GB201907413D0 (en) * 2019-05-24 2019-07-10 Univ Helsinki Viral vector

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4372945A (en) * 1979-11-13 1983-02-08 Likhite Vilas V Antigen compounds
ZA885929B (en) * 1987-08-25 1989-04-26 Oxi Gene Inc Agents for use in tumor or cancer cell killing therapy

Also Published As

Publication number Publication date
AU6176596A (en) 1996-12-30
EP0836480A4 (de) 1999-02-03
WO1996040228A1 (en) 1996-12-19
US6056960A (en) 2000-05-02
US20030113311A1 (en) 2003-06-19
EP0836480B1 (de) 2001-12-12
DE69617956D1 (de) 2002-01-24
DE69617956T2 (de) 2004-08-19
EP0836480A1 (de) 1998-04-22
JPH11512076A (ja) 1999-10-19
CA2224160A1 (en) 1996-12-19
US6514499B1 (en) 2003-02-04
US7341733B2 (en) 2008-03-11

Similar Documents

Publication Publication Date Title
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
TR200200785T2 (tr) 8-Fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-on türevleri
RU94036748A (ru) Церамиды, способ их получения, композиция на их основе и способ гидратирующей обработки кожи или волос
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
NO20002788D0 (no) Nye forbindelser
DK0741710T3 (da) Chlorpyrimidin-mellemprodukter
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
ATE180776T1 (de) Naphthylverbindungen, zwischenprodukte, zusammensetzungen und methoden
EP1409544A4 (de) Humane dr4-antikörper und deren anwendungen
ATE510552T1 (de) Verfahren zur herstellung von sekretierte verkurzte varianten des humanen thyrotropinrezeptors
FI980862A0 (fi) Kiraalisia metyylifenyylioksatsolidinoneja
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
FI972703A0 (fi) Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
IT8921893A0 (it) Procedimento per la produzione di impiallacciatura artificiale ad imitazione della radica, mediante bruciature.
YU63696A (sh) Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova
DE59610251D1 (de) Konjugat, umfassend einen wirkstoff, ein polypeptid und einen polyether
DK0556322T3 (da) Aminosulfonylurinstof-ACAT-inhibitorer
ATE210460T1 (de) Zusammensetzungen, welche adp-ribosyltransferase- aktivität aufweisen und methoden für ihre herstellung und die verwendung derselben
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
BG105275A (en) Tan-1057 derivatives
ES2192610T3 (es) Aminouracilos substituidos.
ATE91689T1 (de) Geminale bisphosphonsaeuren und deren derivate als antiarthritische mittel.
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
ATE197645T1 (de) Immunoenzymatisches konjugat, herstellungsverfahren dafür und verwendungen
ITRM930818A0 (it) Procedimento per la produzione in piante di anticorpi ingegnerizzati, anticorpi prodotti e loro uso in diagnosi e terapia.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties